Several new guidance documents issued by the FDA are poised to significantly impact the rare disease development landscape.
Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...
Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, ...
DFS turns pink today; we discover the Essence of goodness in Florida; and well-known travel retail industry figure Mengfuan (Fuan) Tan becomes our first pickleball #KickCancerThoner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results